From: Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke
Variable | Controls | Ischemic stroke | p-value |
---|---|---|---|
Men, n (%) | 19 (68) | 19 (56) | 0.34 |
Age, years (mean ± SD) | 59.3 ± 12.8 | 64.5 ± 12.8 | *0.03 |
BMI, kg/m2 (mean ± SD) | 26.1 ± 3.8 | 26.6 ± 5.5 | 0.84 |
SSS, points (mean ± SD) |  | 49.5 ± 9.2 |  |
mRS, points (mean ± SD) |  | 1.8 ± 1.8 |  |
Smoking | Â | Â | **0.003 |
- Current smokers, n (%) | 4 (14.2) | 9 (26.4) | Â |
- Previous smokers, n (%) | 5 (17.9) | 17 (50.0) | Â |
- Non-smokers, n (%) | 14 (50) | 4 (11.8) | Â |
- Not known, n (%) | 5 (17.9) | 4 (11.8) | Â |
Alcohol consumption a | Â | Â | *0.04 |
< health authorities’ recommendations, n (%) | 18 (64.3) | 25 (73.5) |  |
> health authorities’ recommendations, n (%) | 2 (7.1) | 9 (26.5) |  |
Not known, n (%) | 8 (28.6) | Â | Â |
Anti-inflammatory medication, n (%) | 4 (14.2) | 14 (41.2) | 0.21 |
- Topical steroids | 1 (3.6) | 8 (23.5) | Â |
- NSAID | 3 (10.7) | 5 (14.7) | Â |
- Systemic glucocorticoid | 3 (10.7) | 2 (5.9) | Â |
- Antibodies | Â | 1 (2.9) | Â |
Arterial supply area affected | |||
- Anterior | Â | 16 (52.9) | Â |
- Posterior (PCA & basilar/vertebral) | Â | 6 (17.7) | Â |
- Nuclei | Â | 5 (14.7) | Â |
- Brain stem & spinal cord | Â | 3 (8.8) | Â |
- Fiber tracts | Â | 3 (8.8) | Â |
- Not identified | Â | 1 (2.9) | Â |
Treatment | |||
- Thrombolysis | Â | 5 (14.7) | Â |
- Thrombectomy | Â | 5 (14.7) | Â |
Time to first sample, hours (mean ± SD) |  | 7.5 (5.6) |  |